These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3875887)

  • 21. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
    Jiang D; Flyer DC
    J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance.
    Facchinetti A; Dalla Santa S; Mezzalira S; Rosato A; Biasi G
    J Immunol; 2005 May; 174(9):5398-406. PubMed ID: 15843538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous retroviral env expression in primary murine leukemias: lack of xenotropic antigens but presence of distinct mink cell focus-forming env subtypes correlating with ecotropic virus inoculated and mouse strain.
    Cloyd MW; Evans LH
    J Natl Cancer Inst; 1987 Jan; 78(1):181-9. PubMed ID: 3025502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated immunity to viral proteins in mice bearing Moloney sarcomas.
    Koppi TA; Halliday WJ
    Immunol Lett; 1982 Mar; 4(3):135-40. PubMed ID: 7076284
    [No Abstract]   [Full Text] [Related]  

  • 25. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells.
    Colombo MP; Pierotti MA; Ballinari D; Parmiani G
    Immunobiology; 1983 Aug; 165(2):186-99. PubMed ID: 6605298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic T lymphocyte response to Moloney sarcoma virus.
    Duprez V; Burakoff SJ
    Surv Immunol Res; 1983; 2(3):309-11. PubMed ID: 6609398
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes.
    Wettstein PJ; Colombo MP; Jaenisch R
    J Immunol; 1988 Jun; 140(12):4337-41. PubMed ID: 3286772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organization of murine sarcoma virus genomes.
    Donoghue DJ; Goldfarb MP; Sharp PA; Weinberg RA
    Cold Spring Harb Symp Quant Biol; 1980; 44 Pt 2,():721-6. PubMed ID: 6253206
    [No Abstract]   [Full Text] [Related]  

  • 30. Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome.
    Reddy EP; Smith MJ; Aaronson SA
    Science; 1981 Oct; 214(4519):445-50. PubMed ID: 6170110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent.
    Schwartzberg P; Colicelli J; Goff SP
    J Virol; 1983 May; 46(2):538-46. PubMed ID: 6601726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.
    Holt CA; Osorio K; Lilly F
    J Exp Med; 1986 Jul; 164(1):211-26. PubMed ID: 2425028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).
    Nihrane A; Silver J
    Immunology; 1997 Feb; 90(2):219-28. PubMed ID: 9135550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative immunofluorescence of murine leukemia virus-derived membrane-associated antigens.
    Satake M; Luftig RB
    Virology; 1983 Jan; 124(2):259-73. PubMed ID: 6337447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic T lymphocyte recognition of transfected cells expressing a cloned retroviral gene.
    Flyer DC; Burakoff SJ; Faller DV
    Nature; 1983 Oct 27-Nov 2; 305(5937):815-8. PubMed ID: 6605480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular definition of retrovirus-induced antigens recognized by tumour-specific H-2-restricted cytolytic T lymphocytes.
    Plata F; Langlade-Demoyen P; Abastado JP; Berbar T; Kourilsky P
    J Immunogenet; 1986; 13(2-3):263-8. PubMed ID: 3493297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes.
    Koszinowski UH; Reddehase MJ; Keil GM; Schickedanz J
    J Virol; 1987 Jun; 61(6):2054-8. PubMed ID: 3033334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic masking of nondefective recombinant murine leukemia virus in Moloney virus stocks.
    Fischinger PJ; Blevins CS; Dunlop NM
    Science; 1978 Aug; 201(4354):457-9. PubMed ID: 663667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.
    Biasi G; Collavo D; Chieco-Bianchi L
    J Immunol; 1983 Jul; 131(1):16-8. PubMed ID: 6223070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.